Warm Autoimmune Hemolytic Anemia

Warm Autoimmune Hemolytic Anemia is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as: Warm type haemolytic anaemia · Warm Antibody Autoimmune Hemolytic Anemia · Warm Autoimmune Hemolytic Anemia (WAIHA) · AIHA - Warm Autoimmune Hemolytic Anemia · Warm Autoimmune Haemolytic Anaemia
Classified under: Cardiovascular Diseases
Hemic and Lymphatic Diseases
Immune System Diseases
Indicated drugs: Nipocalimab

Resolves to

Vocabularies

ICD-10D59.11SNOMED CT3978000MedDRA10047822UMLSC0272118

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

1Structured indicationPopulation, line of therapy, route and combination as fields, not prose

33Clinical trialsPhase, status and sponsor resolved per trial

1Drug reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Warm Autoimmune Hemolytic Anemia share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.